Real -world efficacy of switching to faricimab therapy in patients with longstanding neovascular age -related macular degeneration

被引：0
|
作者：
Long Phan [1 ,2 ]
Chin, Jennifer [1 ]
Hong, Thomas [1 ,2 ]
Chang, Andrew [1 ,2 ]
机构：
[1] CUREOS, Sydney, NSW, Australia
[2] Sydney Retina, Sydney, NSW, Australia
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2024年 / 65卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
234
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Switching from ranibizumab and aflibercept to bevacizumab therapy in neovascular age-related macular degeneration patients
    Calugaru, Dan
    Calugaru, Mihai
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2020, 30 (05) : NP1 - NP2
  • [42] Outcomes After Switching to Faricimab for Refractive Macular Edema in Treatment-Experienced Eyes with Neovascular Age-Related Macular Degeneration
    Qaseem, Yaqoob
    Hou, Kirk Kohwa
    Pettenkofer, Moritz S.
    CLINICAL OPHTHALMOLOGY, 2024, 18 : 3097 - 3102
  • [43] Intravitreal Faricimab for Aflibercept-Resistant Neovascular Age-Related Macular Degeneration
    Rush, Ryan B.
    Rush, Sloan W.
    CLINICAL OPHTHALMOLOGY, 2022, 16 : 4041 - 4046
  • [44] Audit of outcomes of intravitreal Faricimab therapy for treatment naive neovascular age -related macular degeneration at a tertiary specialist macular service
    Babiker, Salma
    Madhusudhan, Savita
    Pearce, Ian
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [45] Switching to Faricimab significantly reduces lesion activity of eyes with neovascular age-related macular degeneration in three months
    Gillies, Mark
    Hunt, Adrian
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2023, 51 (09): : 933 - 933
  • [46] Real -world evidence of Faricimab in management of Neovascular Age related Macular Degeneration (nAMD) and Diabetic Macular Oedema (DMO) : Treatment Naive and Suboptimal Responders.
    Sreekala, Savithri
    Melmane, Sneha
    Elsaeed, Mohamed
    Arora, Harbhajan
    Chandran, Manju
    Menon, Geeta
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [47] Real-World Management of Neovascular Age-Related Macular Degeneration in the US
    Moshfeghi, Andrew A.
    Rahimy, Ehsan
    Boucher, Nick
    Sherman, Steven
    Silva, Fabiana Q.
    Moini, Hadi
    Pitcher, John D.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [48] Real-World Prevalence and Progress of Intraretinal and Subretinal Fluid in Eyes Switched to Faricimab for the treatment of Neovascular Age-Related Macular Degeneration
    Karamat, Ayesha Nuri
    Mauger, Stephanie
    O'Neill, Charles Patrick
    Urrea, Anna
    Corradetti, Giulia
    Chauhan, Devinder
    Samarasinghe, Gihan
    Sadda, SriniVas R.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [49] Real-world experience of intravitreal faricimab injection in previously treated neovascular age-related macular degeneration eyes: a case series
    Maria A. Bantounou
    Mohammed Elsheikh
    Adelehin Ijasan
    Cynthia Santiago
    BMC Ophthalmology, 25 (1)
  • [50] RANIBIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN A REAL WORLD CLINICAL SETTING
    Abell, Robin
    Lim, Diane
    Kerr, Nathan
    Allen, Penelope
    Vote, Brendan
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2012, 40 : 103 - 104
12345